Regulation of p53 - insights into a complex process
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The p53 protein is one of the most important tumor suppressor proteins. Normally, the p53 protein is in a latent state. However, when its activity is required, e.g. upon DNA damage, nucleotide depletion or hypoxia, p53 becomes rapidly activated and initiates transcription of pro-apoptotic and cell cycle arrest-inducing target genes. The activity of p53 is regulated both by protein abundance and by post-translational modifications of pre-existing p53 molecules. In the 30 years of p53 research, a plethora of modifications and interaction partners that modulate p53's abundance and activity have been identified and new ones are continuously discovered. This review will summarize our current knowledge on the regulation of p53 abundance and activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 3×
“…binding site, the central acidic domain that contains a second p53 binding site and the C-terminal domain where the ubiquitin ligase activity is localized (Figure 2; Chen, J. et al., 1993; Haupt et al., 1997; Fang et al., 2000; Kawai et al., 2003; Meulmeester et al., 2003; Kulikov et al., 2006).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 3×
“Consistently, point mutations in the p53 oligomerization domain reduce the ability of p53 to bind Mdm2 (Kubbutat et al., 1997; Lomax et al., 1998).”
BackgroundAtmospheric carbon dioxide concentrations over the past 60 million years
Pearson, P. N., & Palmer, M. R. (2000) · Nature · doi:10.1038/35021000 · Cited by 1,771
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“These proteins primarily sequester Mdm2 in the nucleolus which prevents its interaction with p53 (Kamijo et al., 1998; Pomerantz et al., 1998; Honda and Yasuda, 1999; Zhang and Xiong, 1999).”
BackgroundRescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“Only when p53 was deleted as well did the animals develop normally (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundRescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · cited 8×
“Another ubiquitin ligase for Mdm2 is the histone acetyltransferase PCAF (Linares et al., 2007), while the deubiquitinating enzymes USP2a and HAUSP have been shown to remove ubiquitin moieties from Mdm2 (Li, M. et al., 2004; Stevenson et al., 2007).”
BackgroundInfluentialCytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106 · cited 2×
“the p53 protein is, though, also present in the cytoplasm where it promotes apoptosis via direct interactions with pro- and anti-apoptotic proteins, and where it inhibits autophagy, possibly by inhibiting AMP-dependent kinase and by activating mammalian target of rapamycin (mTOR; reviewed in Moll et al., 2006; Green a…”
BackgroundA role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046 · cited 2×
“ATM and ATR phosphorylate p53 at serine 15, and Chk1 and Chk2, which become activated by ATR and ATM, respectively, phosphorylate p53 at serine 20 (Tibbetts et al., 1999; Hirao et al., 2000; Shieh et al., 2000; Hammond et al., 2002; Saito et al., 2002).”
Background
Cited by
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Transient Protein-Protein Interactions: Structural, Functional, and Network Properties
Perkins, J. R., Diboun, I., Dessailly, B. H., Lees, J. G., & Orengo, C. (2010) · Structure · doi:10.1016/j.str.2010.08.007 · Cited by 520
Mdm2 facilitates the association of p53 with the proteasome
Kulikov, R., Letienne, J., Kaur, M., Grossman, S. R., Arts, J., & Blattner, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911716107 · Cited by 94
Self-citationTowards an understanding of the role of p53 in adrenocortical carcinogenesis
Wasserman, J. D., Zambetti, G. P., & Malkin, D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.010 · Cited by 84
“While regulation of p53 levels and activity are intricate processes and are extensively reviewed elsewhere (Boehme and Blattner, 2009,Dai and Gu; 2010,Hock and Vousden; 2010,Kruse and Gu; 2009; Vilborg et al., 2010), this review will consider only a few key components of this process.”
TRIMming p53’s anticancer activity
Elabd, S., Meroni, G., & Blattner, C. (2016) · Oncogene · doi:10.1038/onc.2016.33 · Cited by 43
Self-citation
Metadata
- Authors
- Boehme, K. A., & Blattner, C.
- Venue
- Critical Reviews in Biochemistry and Molecular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-11-20
- Volume
- 44
- Issue
- 6
- Pages
- 367-392
- ISSN
- 0045-6411 (ISSN-L)
- 1040-9238
- 1549-7798
- OpenAlex
- W1988435321
- Cited by
- 105
- References
- 53
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of p53 - insights into a complex process. https://app.cochat.ai/papers/10.3109/10409230903401507
- The paper
- Boehme, K. A., & Blattner, C. (2009). Regulation of p53 - insights into a complex process. Critical Reviews in Biochemistry and Molecular Biology. https://doi.org/10.3109/10409230903401507
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.